Podcast 22 Nov 2024
Could antigen modulation address autoimmune diseases?
To tell us more about antigen modulation this week is Pete Joyce, CEO and co-founder of Grey Wolf Therapeutics.
- Latest Posts
In Depth 21 Nov 2024
Huntington’s disease: a therapeutic field on a bumpy ride
For years, biotechs have been trying to develop medicines to cure the disease but much to no avail. Now, as clinical studies advance, there is hope.
Best in Biotech 21 Nov 2024
Eight areas where gene therapy shines
Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases.
In Depth 20 Nov 2024
Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024
The hypoparathyroidism treatment space has made quite a buzz this year with a major drug approval, acquisition, and significant advances in clinical trials.
Best in Biotech 19 Nov 2024
Six bispecific antibody companies you should know about
Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.
In Depth 18 Nov 2024
What is Abcam’s founder, Jonathan Milner, up to?
Since Abcam was acquired in December 2023, its founder, Jonathan Milner has been very active. Delve into his investment strategy.
ADVERTISEMENT
ADVERTISEMENT
Expert Advice 15 Nov 2024
How biotech startups become unicorns
Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation.
Podcast 15 Nov 2024
Beyond profits: The Bill & Melinda Gates MRI’s mission to combat neglected diseases
This week, our guest is Dr Claire Wagner, head of corporate strategy and market access at the Bill & Melinda Gates Medical Research Institute (Gates MRI).
Best in Biotech 14 Nov 2024
8 biotech companies advancing new treatments for breast cancer in 2024
Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments.
In Depth 13 Nov 2024
Sleep apnea: biotechs snore points in the therapeutic space
Therapeutic strides in biotech are proving to help address different stages of the sleep apnea.
Best in Biotech 12 Nov 2024
Six exosome therapy companies driving development in the field
Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.
Unlocking consistency in ATMP development: How cryopreservation strengthens Europe’s cell therapy supply chain
Discover how innovative cell therapy cryopreservation solutions are strengthening Europe’s ATMP supply chain.
ADVERTISEMENT
